IVA

Inventiva S.A. - ADR

6.15

USD

IVA Earnings Reports

Positive Surprise Ratio

No Data Available for IVA

Next Report

Date of Next Report

Feb 16, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.24

Implied change from Q3 25 (Revenue/ EPS)

-100.00%

Implied change from Q4 24 (Revenue/ EPS)

Inventiva S.A. - ADR earnings per share and revenue

On Nov 21, 2025, IVA reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.25 USD, resulting in a --% surprise. Revenue reached 46.00 thousand, compared to an expected 8.72 million, with a -99.47% difference.

Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and decrease of -100.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

FAQ

What were Inventiva S.A. - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Inventiva S.A. - ADR reported EPS of --, missing estimates by --, and revenue of $46.00K, -99.47% below expectations.

How did the market react to Inventiva S.A. - ADR's Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Inventiva S.A. - ADR expected to report next?

The next earning report is scheduled for Feb 16, 2026.

What are the forecasts for Inventiva S.A. - ADR's next earnings report?

Based on 2 analysts, Inventiva S.A. - ADR is expected to report EPS of -$0.24 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.